Small Group Learning and a Webcast to Educate Clinicians on Nonmelanoma Skin Cancers
Email: [email protected]
NEW YORK (9/1/2021) – DKBmed, LLC is developing two initiatives for dermatologists and oncologists tasked with the care of patients diagnosed with nonmelanoma skin cancers (NMSC). The first program, entitled NMSC: Enhancing Clinical Strategies, will be delivered as an interactive webcast. The second program, Gather-ed: Nonmelanoma Skin Cancer, will bring together 10 groups of 10 to 15 professionally connected clinicians. NMSC experts, Vishal Patel, MD, FAAD, FACMS and Emily S. Ruiz, MD, MPH, will mentor and lead groups.
According to the American Cancer Society, skin cancer is the most common kind of cancer in the United States, with about 5.4 million being diagnosed with basal cell carcinomas (BCCs) or squamous cell carcinomas (SCCs) annually. Although the 10-year survival rate after surgery exceeds 90%, patients with metastases still experience relatively poor outcomes and lower odds for survival. In recent years, treatments for BCCs and SCCs have improved markedly with the development of immune checkpoint inhibitors, which have clear, clinical utility for high-mutational burden tumors associated with NMSC. That said, the continually evolving therapeutic landscape challenges oncologists, dermatologists, and others who treat patients with NMSC.
“Recent clinical research advances have led to patient benefit. While exciting, the rapidity of this data has led to gaps in knowledge, awareness and confidence for oncologists, dermatologists, and others who treat patients with NMSC.” Notes Omid Hamid, MD, Co-Director of Cutaneous Oncology at The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate. “Staying updated on the latest clinical data is always a priority and a never-ending challenge.”
NMSC: Enhancing Clinical Strategies will address these challenges and depart from traditional, didactic webcasts by employing a suite of interactive resources, which include:
- Embedded presentations of pertinent clinical trial data for new and emerging treatments developed for skin cancer
- Mechanism-of-action videos
- In-activity problem solving
- Links to additional resources to support further NMSC education
Gather-ed: Nonmelanoma Skin Cancer will immerse learners in a rich, personalized educational experience that features and prioritizes learner-to-learner and learner-to-group leader interactions. The format supports hybrid or blended learning. Learners asynchronously complete foundational materials, and the group leaders direct activities that focus on areas of greatest concern in the care of patients with skin cancer. Through the Gather-ed platform:
- Group leaders will invite clinicians to participate from their ‘practice community’.
- After onboarding, group leaders will guide learners through the components of a multipart curriculum that includes self-study modules, live group discussions, and collaborative group tasks. Group leaders assign tasks, introduce case studies, and coordinate live discussions with group members while providing ongoing support and mentoring to participating clinicians.
About ArcheMedX ILPThe ArcheMedX ILP is a system that intelligently maps medical education content and assesses learner engagement in real-time to curate customized learning experiences. Participants are driven to reflect and engage with content by answering questions, taking notes, and viewing additional resources. By organizing content into one place, ArcheMedX ILP offers users a streamlined, elegant learning experience. To learn more about the features of the ArcheMedX ILP, visit the company website at: https://www.archemedx.com/intelligent-learning-platform/.
About Gather-edThe Gather-ed digital platform offers a social learning experience that prioritizes interactions and individual contributions within the group setting. Participants have the ability to collaborate with colleagues and engage in thoughtful discussions structured by their group leader. By connecting professionals in intimate group settings, Gather-ed facilitates transformative educational experiences that improve teamwork, increase connectedness, and ultimately strengthen patient-provider relationships.
About the Postgraduate Institute of MedicineFounded in 1979, the Postgraduate Institute of Medicine (PIM) is a nationally accredited, independent provider of continuing education for healthcare professionals. PIM is a recognized leader in the field and specializes in joint providership, outcomes measurement, as well as grant solicitation and funding support. In addition to these services, PIM also offers an eLearning program with traffic guarantees available at https://www.cmeuniversity.com/. To learn more about PIM, visit their website at: https://www.pimed.com/.
About DKBmedDKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.
Working with accredited providers and other partners, DKBmed develops innovative educational programs and quality improvement (QI) initiatives, bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in Pain Management, HIV, Depression, Influenza, and Diabetic Eye Disease. DKBmed was also an early adopter of case scenarios with real patients and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, and smart phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn and access educational programs in a manner that is most convenient and appropriate for them.
DKBmed’s programs are accessible through the company’s website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.